IDEX CORP /DE/

IDEX CORP /DE/ (IEX) — Investment Memo

🐂 The Bull Case (Warren's voice)

• The "Toll Bridge" Model: IDEX doesn't sell luxuries; they sell mission-critical components. When a valve is embedded in a multi-million dollar medical diagnostic tool or a chemical plant, the cost of the part is negligible compared to the catastrophic risk of replacing it with an unproven alternative.
• Pricing Power by Default: Because the switching costs are so high, IDEX possesses a natural ability to raise prices to offset inflation without losing customers. It is a business of necessity, not preference.
• Diversified Resilience: By operating across health, science, and industrial sectors, they avoid the "single-point-of-failure" risk. If industrial Capex dips, health-tech spending often offsets it.
• The Entry Price: This becomes attractive only when the market forgets the value of the "lock-in" and prices it like a generic industrial manufacturer. We want it at a price where the stagnant growth is already baked in, leaving the moat as a free call option.

🐻 The Bear Case (Charlie inverts)

• The Roll-Up Treadmill: Management is addicted to acquisitions to mask organic stagnation. This is the classic "empire-building" trap: buying growth at high multiples to report revenue increases, while the actual return on invested capital (ROIC) decays. If the music stops (credit tightens or multiples compress), the facade collapses.
• Structural Obsolescence: The moat is "switching costs," but that only works if the technology remains relevant. If a competitor introduces a disruptive, modular, "plug-and-play" fluidics platform that removes the need for specialized integration, the lock-in vanishes overnight.
• The ROE Death Spiral: A falling ROE (now 12.0%) suggests the company is becoming less efficient at generating profit from its capital. A business that requires constant shopping to stay relevant is not a compounder; it's a collector.
• Most Likely Failure: The "Treadmill Effect." Over the next 3–5 years, the most likely scenario is a continued slide in ROE as they overpay for mediocre acquisitions to maintain the illusion of growth, effectively destroying shareholder value through capital misallocation.

💰 Valuation & Margin of Safety

• Intrinsic value estimate: $162.83 per share.
• 25% margin of safety entry: $122.12 (conservative).
• 50% margin of safety entry: $81.42 (Buffett's ideal).
• Current Status: Expensive/Fair. At the current DCF valuation, we are paying for a growth rate (6.9%) that management is struggling to achieve organically. We are paying a premium for a moat that is visibly leaking.

Verdict: PASS

The business has a decent moat, but management is using acquisitions as a prosthetic for organic growth. We do not buy "empire builders" at fair value. Unless the price drops to $122 or lower, the risk of capital misallocation outweighs the stability of the switching costs.